drugset

drugset / Trial / NCT00689572

New Medication Treatment for Stimulant Dependence

NCT00689572 ↗

Phase 2 Completed 108 enrolled University of Virginia National Institute on Drug Abuse (NIDA) · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy of ondansetron compared with placebo in the treatment of cocaine dependence.

Timeline

Start: 2008-07
Primary completion: 2013-12
Completion: 2013-12

Publications

Blevins D, Seneviratne C, Wang XQ, Johnson BA, Ait-Daoud N. A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis. Drug Alcohol Depend. 2021 Nov 1;228:109074. doi: 10.1016/j.drugalcdep.2021.109074. Epub 2021 Sep 24.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ondansetron	Other / unclassified	4 mg	—

Indications